Cerus Corporation (CERS) soars on Swiss approval: HSC members take 53.7% gains in 15 days
Today's Financial News - Posted August 19, 2009
Great news from Switzerland: Cerus Corporation (NASDAQ:CERS) has gained approval for Intercept. Followers of TFN’s Laura Cadden are rubbing their hands, solid profits jingling in their pockets
by J. Christoph Amberger
Baltimore, MD — TFN: ”If you took my advice on July 29 and picked up shares of Cerus Corporation (NASDAQ:CERS), you should be sitting on over 30% gains,” wrote Laura Cadden this morning.
“We anticipated the share price would leap by at least 20% when Cerus received U.S. FDA approval of its INTERCEPT system for the cleansing of donated blood components. But news that Swiss approval has been granted had done the trick.
“The share price is rising and dropping like mad, so let’s grab those gains today. We’ll look to get back in this stock later when the price drops back again. Sell your shares of Cerus Corporation (NASDAQ:CERS) and enjoy your gains.”
Laura hands HSC Members double-digit gainer #45 this year
This is not just the perfect example of the kind of sell alerts subscribers to our premium service Hot Stock Confidential receive when stocks are ripe for the pickin’. It also underlines Laura’s sense of understatement. Because readers who took her advice were able to walk away with far more than 20% gains jingling in their pockets: HSC recorded a gain of 53.7% on CERS in just 15 days.
That’s better than most $1,000-plus-a-year trading services make you!
This is double-digit gainer #45 so far this year for HSC members in 2009. Including our 11 losing recommendations in that period, we’ve so far averaged 18.1% on our closed positions, with an average holding period of 51 days.
(The average gain on our winners has been 31.6% in 47 days.)
Now, my friend, I know you may think it’s boring and self-serving that I keep harping on the success of our Hot Stock Confidential team. But could it be that’s just because you’ve not been part of its success. Frankly, I’d rather we serve you!
Give it some thought. Our subscription fee is so reasonable, you’d have made our quarterly subscription fee back (and then some!) by simply investing $500 in any of our closed positions. Ther rest would’ve been gravy! Just give me a sec to try and talk you into it…
Next Article: TFN eNews 08/18/2009: The most under-rated action in the world’s energy sector
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down